Therapeutic Drug Monitoring: A Tool to Individualize Highly Active Antiretroviral Therapy in HIV Infected Patients

Publisher： Bentham Science Publishers

E-ISSN： 1875-676x|2|3|205-217

ISSN： 1573-4129

Source： Current Pharmaceutical Analysis, Vol.2, Iss.3, 2006-08, pp. : 205-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Highly Active Antiretroviral Therapy and Cardiovascular Complications in HIV-Infected Patients

By  

Current Pharmaceutical Design, Vol. 9, Iss. 18, 2003-07 ,pp. : 1475-1481

Bentham Science Publishers

Access to resources Recommend Favorite

High Variability of Indinavir and Nelfinavir Pharmacokinetics in HIV-Infected Patients with a Sustained Virological Response on Highly Active Antiretroviral Therapy

By Goujard Cécile  

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1267-1278

Adis International

Access to resources Recommend Favorite

Despite limitations, therapeutic drug monitoring may be of value in antiretroviral treatment in HIV-infected patients

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 7, 2005-07 ,pp. : 24-26

Adis International

Access to resources Recommend Favorite

Therapeutic Drug Monitoring in the Management of HIV-Infected Patients

By  

Current Medicinal Chemistry, Vol. 15, Iss. 19, 2008-08 ,pp. : 1925-1939

Bentham Science Publishers

Access to resources Recommend Favorite

Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients

By Harris Marianne  

Expert Opinion on Drug Safety, Vol. 7, Iss. 4, 2008-07 ,pp. : 389-400

Informa Healthcare

Access to resources Recommend Favorite